A detailed history of Smartleaf Asset Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 558 shares of RGEN stock, worth $79,559. This represents 0.01% of its overall portfolio holdings.

Number of Shares
558
Previous 63 785.71%
Holding current value
$79,559
Previous $7.98 Million 921.04%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.79 - $167.35 $59,296 - $82,838
495 Added 785.71%
558 $81.4 Million
Q2 2024

Aug 13, 2024

BUY
$120.0 - $182.95 $5,400 - $8,232
45 Added 250.0%
63 $7.98 Million
Q1 2024

Oct 07, 2024

SELL
$170.78 - $208.42 $7,685 - $9,378
-45 Reduced 71.43%
18 $3.33 Million
Q1 2024

May 02, 2024

BUY
$170.78 - $208.42 $2,903 - $3,543
17 Added 1700.0%
18 $741,000
Q4 2023

Feb 12, 2024

BUY
$114.17 - $185.35 $114 - $185
1 New
1 $0

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.